Tyvaso Treatment Tracker

Keeping track of your 4 times daily dosing is important to your pulmonary arterial hypertension (PAH) treatment success. In your first Tyvaso shipment from your Specialty Pharmacy Services (SPS) provider, you’ll receive the Tyvaso Treatment Tracker, which is designed to help you track the number of breaths you take during each of your treatment sessions.

The Treatment Tracker is a monthly, personal diary that allows you to record treatment sessions. The diary consists of daily calendars organized by week. Each day, you’ll check 1 circle for every breath of Tyvaso taken during your individual treatment sessions. For example, if your doctor prescribes 9 breaths of Tyvaso per treatment session, you’ll make sure to record your breaths by checking 9 circles (for 9 breaths) 4 times each day.

Download your Treatment Tracker now

IMPORTANT SAFETY INFORMATION FOR TYVASO

Before you take Tyvaso, tell your healthcare provider about all of your medical conditions, including if you:

It is important to tell your healthcare provider about all the medicines you may be taking, including prescription and non-prescription medicines, vitamins, and herbal supplements, as they may affect your use of Tyvaso by increasing the risk of side effects or decreasing effectiveness. Especially tell your healthcare provider if you take any of these medicines:

The most common side effects of Tyvaso are coughing, headache, throat irritation and pain, nausea, reddening of the face and neck (flushing), and fainting or loss of consciousness. These are not all the possible side effects of Tyvaso. Tell your healthcare provider about any side effects that bother you or do not go away. Your healthcare provider may be able to help you manage the side effects.

INDICATION

Tyvaso is a prescription medicine used in adults to treat pulmonary arterial hypertension (PAH) (WHO Group 1), which is high blood pressure in the arteries of your lungs. Tyvaso can improve exercise ability in people who also take bosentan (an endothelin receptor antagonist, (ERA)) or sildenafil (a phosphodiesterase-5 (PDE-5) inhibitor). Your ability to do exercise decreases 4 hours after taking Tyvaso.

The effects of Tyvaso are unknown in patients under 18 years of age.

TYVISIdtcJUN16

Please see the Full Prescribing Information, Patient Package Insert, and the Tyvaso Inhalation System Instructions for Use manual.

For additional information about Tyvaso, visit www.tyvaso.com or call 1-877-UNITHER (1-877-864- 8437).

Call your healthcare provider for medical advice about side effects. You may report side effects to the FDA at www.fda.gov/MedWatch or call 1-800-FDA-1088.

This information is provided for an informational purpose and is not intended as treatment advice. Patients should consult a healthcare professional for treatment advice.